26832-96-2

Basic information

• Product Name: (4-FLUOROPHENYLAMINO)METHYLENEMALONIC ACID DIETHYL ESTER
• Synonyms: DIETHYL 2-[(4-FLUOROANILINO)METHYLENE]MALONATE;(4-FLUOROPHENYLAMINO)METHYLENEMALONIC ACID DIETHYL ESTER;diethyl 2-(((4-fluorophenyl)amino)methylene)malonate;2-[(4-Fluoro-phenylamino)-methylene]-malonic acid diethyl ester
• CAS NO: 26832-96-2
• Molecular Formula: C₁₄H₁₆FNO₄
• Molecular Weight: 281.28
• Mol File: 26832-96-2.mol
• Article Data: 30

Chemical Properties

• Melting Point: 48-50 °C(Solv: ethanol (64-17-5))
• Boiling Point: 333.5°C at 760 mmHg
• Flash Point: 155.5°C
• Appearance: /
• Density: 1.228g/cm³
• Vapor Pressure: 0.000136mmHg at 25°C
• Refractive Index: 1.538
• PKA: -0.70±0.70(Predicted)
• CAS DataBase Reference: (4-FLUOROPHENYLAMINO)METHYLENEMALONIC ACID DIETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (4-FLUOROPHENYLAMINO)METHYLENEMALONIC ACID DIETHYL ESTER(26832-96-2)
• EPA Substance Registry System: (4-FLUOROPHENYLAMINO)METHYLENEMALONIC ACID DIETHYL ESTER(26832-96-2)

Safety Data

• Hazardous Substances Data: 26832-96-2(Hazardous Substances Data)

Usage

General Description

(4-Fluorophenylamino)methylenemalonic acid diethyl ester is a chemical compound with the molecular formula C14H15FNO4. It is a diethyl ester derivative of malonic acid with a substituted amino group and a fluorine atom attached to the phenyl ring. (4-FLUOROPHENYLAMINO)METHYLENEMALONIC ACID DIETHYL ESTER has potential applications in organic synthesis and pharmaceutical research due to its unique chemical structure and reactivity. It may be used as a building block in the synthesis of various biologically active molecules and pharmaceutical intermediates. However, it is important to handle and use this compound with caution, as it may have potential health and environmental hazards.

InChI:InChI=1/C14H16FNO4/c1-3-19-13(17)12(14(18)20-4-2)9-16-11-7-5-10(15)6-8-11/h5-9,16H,3-4H2,1-2H3

Upstream product

• 87-13-8 diethyl 2-ethoxymethylenemalonate 
• 371-40-4 4-fluoroaniline 
• 40131-09-7 diethyl methoxymethylenemalonate 
• 105-53-3 diethyl malonate 

Downstream Products

• 318-35-4 ethyl 6-fluoro-4-hydroxy-3-quinoline-carboxylate 
• 71083-00-6 ethyl 6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate 
• 923585-83-5 4-[4-(3,4-dimethylpiperazin-1-yl)phenylamino]-6-fluoroquinoline-3-carboxylic acid ethyl ester 
• 923585-84-6 6-fluoro-4-[4-(3,3,4-trimethylpiperazin-1-yl)phenylamino]quinoline-3-carboxylic acid ethyl ester 
• 915723-07-8 (R)-4-[4-(3,4-dimethylpiperazin-1-yl)phenylamino]-6-fluoroquinoline-3-carboxylic acid ethyl ester 
• 77779-49-8 4-chloro-6-fluoroquinoline-3-carboxylic acid ethyl ester 
• 343-10-2 6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 343-10-2 6-fluoro-4-hydroxy-quinoline-3-carboxylic acid 
• 391-78-6 6-Fluoro-4-hydroxyquinoline 
• 391-77-5 4-Chloro-6-fluoroquinoline 
• 1435910-85-2 ethyl 6-fluoro-1-(oxiran-2-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate 
• 1456629-63-2 1-ethyl-6-fluoro-4-oxo-1,4-dihydro-3-[1-oxo-2-hydrazino-3-{p-toluenesulfon}]quinoline 
• 1462359-43-8 6-fluoro-4-oxo-1,4-dihydro-3-[1-oxo-2-hydrazino-3-{p-toluenesulfonyl}]quinoline 
• 1018135-33-5 6-fluoro-1,4-dihydro-4-oxoquinoline-3-carbohydrazide 

Relevant articles and documents

Bacterial patterning controlled by light exposure

Patterning of multiple bacterial strains in one system is achieved by employing a single photo-activated antibiotic. Varying the light-exposure time results in zones with mixed and single populations.

3-(Benzo[: D] thiazol-2-yl)-4-aminoquinoline derivatives as novel scaffold topoisomerase i inhibitor via DNA intercalation: Design, synthesis, and antitumor activities

Twenty-seven 3-(benzo[d]thiazol-2-yl)-4-aminoquinoline derivatives have been designed and synthesized as topoisomerase I inhibitors. The in vitro anti-proliferation evaluation against four human cancer cell lines (MGC-803, HepG-2, T24, and NCI-H460) and one normal cell line (HL-7702) indicated that most of them exhibited potent cytotoxicity. Among them, 5a was identified as the most promising candidate with a low IC50 value of about 2.20 ± 0.14 and was selected for further exploration. Spectroscopic analyses and agarose-gel electrophoresis assays indicated that 5a could interact with DNA and strongly inhibit topoisomerase I (Topo I). Further screening of the Topo I activity of compounds 5b, 5c, 5e, 5f, 5h, 5i, 5j, 5l, and 5n suggested that some of the compounds might exert quite a different cytotoxicity profile to that of 5a. Molecular modeling studies confirmed that 5a adopts a unique mode to interact with DNA and Topo I. Other molecular mechanistic studies suggested that the treatment of MGC-803 cells with 5a induces S phase arrest, up-regulates the pro-apoptotic protein, down-regulates the anti-apoptotic protein, activates caspase-3, and subsequently induces mitochondrial dysfunction so as to induce cell apoptosis. The in vivo efficiency of 5a was also evaluated on MGC-803 xenograft nude mice and the relative tumor growth inhibition was 42.4percent at 12 mg kg-1 without an obvious loss in the body weight. This journal is

6-substituted-1-((1-substituted phenyl-1,2,3-triazole-4-yl)methyl)-4-carbonylquinoline-3-carboxylic acid or pharmaceutical salt, preparation and application

The present invention belongs to the technical field of organic synthesis, and specifically discloses 6-substituted-1-((1-substituted phenyl-1,2,3-triazole-4-yl)methyl)-4-carbonylquinoline-3-carboxylic compounds or a pharmaceutical salt thereof, and prepa